Page last updated: 2024-10-28

hexamethonium and Inflammatory Bowel Diseases

hexamethonium has been researched along with Inflammatory Bowel Diseases in 1 studies

Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.

Inflammatory Bowel Diseases: Chronic, non-specific inflammation of the GASTROINTESTINAL TRACT. Etiology may be genetic or environmental. This term includes CROHN DISEASE and ULCERATIVE COLITIS.

Research Excerpts

ExcerptRelevanceReference
"Pretreatment with nicotine significantly decreased each of these markers in vagotomized mice with DSS colitis, and all markers except DAI and IL-6 in sham-operated DSS-treated mice."1.33The vagus nerve: a tonic inhibitory influence associated with inflammatory bowel disease in a murine model. ( Blennerhassett, P; Collins, SM; Ghia, JE; Kumar-Ondiveeran, H; Verdu, EF, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ghia, JE1
Blennerhassett, P1
Kumar-Ondiveeran, H1
Verdu, EF1
Collins, SM1

Other Studies

1 other study available for hexamethonium and Inflammatory Bowel Diseases

ArticleYear
The vagus nerve: a tonic inhibitory influence associated with inflammatory bowel disease in a murine model.
    Gastroenterology, 2006, Volume: 131, Issue:4

    Topics: Animals; Anticoagulants; Appetite Depressants; Dextran Sulfate; Dinitrofluorobenzene; Disease Models

2006